000 | 01552 a2200481 4500 | ||
---|---|---|---|
005 | 20250512092813.0 | ||
264 | 0 | _c19680906 | |
008 | 196809s 0 0 eng d | ||
022 | _a0018-0203 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCruchaud, A | |
245 | 0 | 0 |
_aTreatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data. _h[electronic resource] |
260 |
_bHelvetica medica acta _cDec 1967 |
||
300 |
_a5-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Antinuclear _xanalysis |
650 | 0 | 4 | _aAntibody Formation |
650 | 0 | 4 |
_aAutoantibodies _xanalysis |
650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
650 | 0 | 4 |
_aComplement System Proteins _xanalysis |
650 | 0 | 4 | _aDiphtheria Toxoid |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypersensitivity, Delayed _xetiology |
650 | 0 | 4 | _aLatex Fixation Tests |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNitrobenzenes |
650 | 0 | 4 |
_aSalmonella paratyphi A _ximmunology |
650 | 0 | 4 | _aTetanus Toxoid |
650 | 0 | 4 | _aTuberculin Test |
650 | 0 | 4 | _aVaccination |
650 | 0 | 4 |
_agamma-Globulins _xanalysis |
700 | 1 | _aPometta, D | |
700 | 1 | _aRousso, C | |
773 | 0 |
_tHelvetica medica acta _gvol. 34 _gno. 1 _gp. 5-22 |
|
999 |
_c4179244 _d4179244 |